Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4151
Nuveen ESG Large-Cap Growth ETF
NULG
$2.6B
| $151K | ﹤0.01% |
2,300
-250
| -10% | -$16.8K |
|
4152
Driven Brands
DRVN
$2.47B
| $150K | ﹤0.01% |
5,207
+251
| +5% | +$7.44K |
|
4153
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.83B
| $150K | ﹤0.01% |
3,210
+1,853
| +137% | +$88.8K |
|
|
ZEV
4154
DELISTED
Lightning eMotors, Inc.
ZEV
| $150K | ﹤0.01% |
880
+785
| +826% | +$126K |
|
4155
Bank of Marin Bancorp
BMRC
$460M
| $148K | ﹤0.01% |
3,929
-5,175
| -57% | -$180K |
|
4156
Camden National
CAC
$988M
| $148K | ﹤0.01% |
3,090
-2,640
| -46% | -$122K |
|
|
CGAU
4157
Centerra Gold
CGAU
$3.33B
| $148K | ﹤0.01% |
21,742
-28,987
| -57% | -$215K |
|
4158
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.87B
| $148K | ﹤0.01% |
5,411
-701,660
| -99% | -$19.2M |
|
|
BMTC
4159
DELISTED
Bryn Mawr Bank Corp
BMTC
| $147K | ﹤0.01% |
3,205
-10,040
| -76% | -$405K |
|
4160
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$430M
| $146K | ﹤0.01% |
5,932
-13,183
| -69% | -$323K |
|
4161
iShares US Regional Banks ETF
IAT
$673M
| $146K | ﹤0.01% |
2,413
-100
| -4% | -$5.75K |
|
4162
Liberty Energy
LBRT
$2.79B
| $146K | ﹤0.01% |
12,074
-12,763
| -51% | -$141K |
|
4163
Orion
OEC
$403M
| $146K | ﹤0.01% |
8,043
+3,341
| +71% | +$59.8K |
|
4164
Uranium Energy
UEC
$4.47B
| $146K | ﹤0.01% |
47,896
+17,688
| +59% | +$44.3K |
|
4165
Utz Brands
UTZ
$1.24B
| $146K | ﹤0.01% |
8,511
+4,106
| +93% | +$83.4K |
|
|
FLXN
4166
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $146K | ﹤0.01% |
23,901
-264,527
| -92% | -$1.65M |
|
4167
AvePoint
AVPT
$2.76B
| $145K | ﹤0.01% |
+17,072
| New | +$170K |
|
4168
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
| $145K | ﹤0.01% |
2,446
-7,877
| -76% | -$481K |
|
|
GLDD
4169
DELISTED
Great Lakes Dredge & Dock
GLDD
| $145K | ﹤0.01% |
9,637
+5,136
| +114% | +$76.3K |
|
|
SNCY
4170
DELISTED
Sun Country Airlines
SNCY
| $145K | ﹤0.01% |
4,309
+511
| +13% | +$17K |
|
4171
iShares MSCI United Kingdom Small-Cap ETF
EWUS
$41.4M
| $144K | ﹤0.01% |
3,082
-3,068
| -50% | -$149K |
|
4172
iShares MSCI Brazil Small-Cap ETF
EWZS
$228M
| $144K | ﹤0.01% |
9,000
-129,855
| -94% | -$2.29M |
|
4173
Pulmonx
LUNG
$52.8M
| $144K | ﹤0.01% |
3,991
+2,416
| +153% | +$95.1K |
|
4174
Celestica
CLS
$37.8B
| $143K | ﹤0.01% |
16,112
-21,481
| -57% | -$184K |
|
4175
Stoneridge
SRI
$200M
| $143K | ﹤0.01% |
7,037
+1,175
| +20% | +$29.1K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.